Rule 1: Molecules that contain certain functional groups such as the nitro group (-NO2) or phosphate group (-OPO3H2).
Rule 2: Molecules with higher molecular weights and greater hydrophobicities that can cross cell membranes can lead to increased exposure and potential toxicity.
Rule 3: The presence of a carbamate group (-CONHC-) or a chiral center can lead to different biological activities and toxicities.
Rule 4: Molecules containing functional groups like carbonyl or carboxylic acid may lead to toxicity due to their increased reactivity.

Rule 5: Molecules with high molecular weight.

Rule 6: Compounds containing aromatic rings.

Rule 7: Molecules containing functional groups such as fluorine atoms or nitro groups may increase adverse effects on human health.

Rule 8: Molecules with a heterocyclic ring structure may have a higher probability of causing adverse effects.

Rule 9: Molecules that contain functional groups such as C=O or CC.

Rule 10: Molecules containing a metal ion such as Cl or Na may not have the potential to cause adverse effects in individuals with congenital, familial, and genetic disorders.

Rule 11: Molecules that contain a phosphorus atom bonded to four other atoms including two oxygen atoms or a sulfonamide group (-SO2NH-) attached to an aromatic ring or a nitro group (-NO2) attached to an aromatic ring may have the potential to cause adverse effects.

Rule 12: Molecules containing the substructure "C#N" or "Cc1ccccc1" or "C(=O)O" in their SMILES representation may have the potential to cause adverse effects related to congenital, familial, and genetic disorders.

Rule 13: Where a molecule contains a bromine atom or fluorine atom bonded to a carbon atom or a cyano group (-CN), it may have the potential to cause adverse effects.

Rule 14: If the molecule contains the SMILES string "CC#N" or "Cc1ccccc1".

Rule 15: If a molecule contains functional groups like the sulfonyl group (-SO2R) or nitro group (-NO2).

Rule 16: If the molecule contains a benzene ring or a halogen atom (such as chlorine or fluorine) attached to a carbon atom, it may cause adverse effects related to congenital, familial and genetic disorders.

Rule 17: If the molecule contains a benzene ring or any other aromatic system or any metal ion or fluorine atoms, then it may have the potential to cause adverse effects.

Rule 18: If a molecule contains a functional group called "carbonyl" (represented by the symbol "C=O" in the SMILES notation) followed by another carbonyl group or a nitrogen atom.
Rule 1: If a molecule contains a sulfonyl group (-SO2-), it may be associated with potential adverse effects related to congenital, familial, and genetic disorders.
Rule 2: If a molecule contains a guanidine group (-NH-C(=NH2)-NH-), it could potentially cause adverse effects related to congenital, familial, and genetic disorders.
Rule 3: Molecules containing a nitro group (-NO2) may be associated with the potential to cause adverse effects related to cancer or other diseases.
Rule 4: Molecules with a sulfhydryl group (-SH) could have the potential to cause adverse reactions such as skin rashes, liver damage, and other serious health problems.
Rule 5: Molecules containing a halogen atom (such as chlorine or fluorine) attached to a carbon atom, may cause reproductive toxicity, neurotoxicity, and carcinogenicity. 
Rule 6: If a molecule's molecular formula contains sodium ions or indium ions, it may be associated with potential adverse effects in humans.
Rule 7: Molecules containing benzene rings or polycyclic aromatic hydrocarbons may have potential adverse effects in humans.
Rule 8: Molecules containing a carboxylate ion (-COO-) or a carbonate ion (-CO3^2-) could have potential adverse effects in patients.
Rule 9: The presence of a chlorine atom attached to a carbon atom in a molecule may cause adverse effects related to congenital, familial, and genetic disorders.
Rule 10: If a molecule contains a cyano group (-CN) or a fluoro group (-F), then it may have the potential to cause adverse effects related to congenital, familial, and genetic disorders.
Rule 11: The molecular structure of a compound, particularly the presence of "-CC-" or "-CH=CH-" functional groups, can lead to potential adverse effects.
Rule 12: If a molecule contains a sulfonamide group (-SO2NH-), it may have the potential to cause adverse effects related to congenital, familial, and genetic disorders.
Rule 13: Molecules containing a quinazoline or coumarin ring system may lead to potential adverse effects related to cancer or genetic disorders.
Rule 14: A molecule with a functional group such as "-CCl" or "-SCN" may have adverse effects on the body.
Rule 15: If a molecule contains functional groups, such as isocyanate (-N=C=O) or a halogen atom, it may increase its toxicity, thus could have potential for causing adverse effects. 
Rule 16: The size, shape, and charge of a molecule play crucial roles in determining its potential for biological effects like toxicity and adverse effects.
Rule 17: If a molecule contains a sulfonamide group (-SO2NH-) and a quinolone ring system, it has the potential to cause adverse effects.
Rule 18: The presence of certain functional groups like sulfonamide, nitro, halogen groups, or a high degree of lipophilicity in a molecule might increase its potential for causing adverse effects.
Rule 19: If a molecule contains a chlorine atom bonded to two carbon atoms, it may be linked with potential adverse effects related to congenital, familial, genetic disorders.
Rule 20: If a molecule contains a nitro group (-NO2) attached to a carbon atom, or a sulfonate group (-SO3H) or sulfate group (-OSO3H) attached to a benzene ring, it may have potential adverse effects.
Rule 1: If a molecule contains a sulfonyl group (-SO2-) or a carbonyl group (-C=O), then it may have the potential to cause adverse effects.
Rule 2: The molecules with any functional group such as "CCOO" or "CCON" in the molecular structure may have potential side effects on congenital, familial and genetic disorders.
Rule 3: If a molecule contains aromatic rings like "CC1=NN=C(C=C1)C" or "CC1=NN=C(CS1)C".
Rule 4: Molecules with multiple halogen atoms such as chlorine or fluorine may increase the likelihood of causing adverse effects by altering the chemical and physical properties of the molecule.
